Some individuals in research-peptide communities use GHK-Cu via subcutaneous injection or other systemic routes, extrapolating from animal studies and topical findings
After an initial loading regimen of 1mg three times weekly for two weeks, maintenance therapy is typically 1mg every three months for life in conditions like pernicious anaemia, or every two months if neurological involvement was present
It supports studies of tissue response signaling, cell behavior, and cytoskeleton associated pathways in controlled in vitro and preclinical model systems
It may be a couple of days before you notice, or it could be sooner
Listen to your body: if you feel fantastic and full of vitality, your plan is likely working and you might stick to it or even lengthen the interval between drips
For example, combinations of GLP-1/glucagon RA achieve more liver fat content reduction in people with MASLD compared to GLP-1 RA alone despite similar WL, likely due to the direct effect of glucagon on hepatic lipid oxidation [79]